Skip to main content
Erschienen in: Clinical Rheumatology 8/2017

06.06.2017 | Original Article

Comparison of systemic lupus erythematosus (SLE) patients managed early after diagnosis in specialty versus community care clinics

verfasst von: Roaa Aljohani, Dafna D. Gladman, Jiandong Su, Murray B. Urowitz

Erschienen in: Clinical Rheumatology | Ausgabe 8/2017

Einloggen, um Zugang zu erhalten

Abstract

To compare management and outcomes of SLE patients treated in community clinics (Cc) with those treated in specialty clinic (Sc) within 10 years after SLE diagnosis. A single-center, matched cohort study design was used. We identified 54 SLE patients who were referred to a Sc from Cc within 5 years of SLE diagnosis, and 101 inception SLE patients who followed in a Sc. Patients in Cc were matched 1:2 based on gender, decade of SLE diagnosis, and age at diagnosis within 3 years with Sc patients. Disease characteristics, damage accumulation, death, cardiovascular (CVS) risk factors, and events were compared at 5 and 10 years of disease. Regression analyses taking into account the paired data were conducted. At 5 years of disease, patients referred from Cc had less cumulative ACR criteria, but more active disease. They were on higher doses of glucocorticoids (GCS) but less antimalarial treatment. At 10 years of disease and follow-up entirely in Sc, Sc patients had less disease activity. They had lower cumulative GCS doses. They had less hypertension and osteoporosis but more hypercholesterolemia than Cc patients. No statistically significant difference in damage accrual, CVS events, and death were detected. Regression analysis confirmed an association between being inception Sc patients and less active disease at 10 years. Lupus patients should be under the care of a lupus specialist early in their disease course for better control of their disease activity and to minimize use of GCS.
Literatur
1.
Zurück zum Zitat Swaak AJG, van den Brink HG, Smeenk RJ, Manger K, Kalden JR, Tosi S et al (1999) Systemic lupus erythematosus: clinical features in patients with a disease duration of over 10 years, first evaluation. Rheumatology (Oxford, England) 38:953–958CrossRef Swaak AJG, van den Brink HG, Smeenk RJ, Manger K, Kalden JR, Tosi S et al (1999) Systemic lupus erythematosus: clinical features in patients with a disease duration of over 10 years, first evaluation. Rheumatology (Oxford, England) 38:953–958CrossRef
2.
Zurück zum Zitat Urowitz MB, Kagal A, Rahman P, Gladman DD (2002) Role of specialty care in the management of patients with systemic lupus erythematosus. J Rheumatol 29:1207–1210PubMed Urowitz MB, Kagal A, Rahman P, Gladman DD (2002) Role of specialty care in the management of patients with systemic lupus erythematosus. J Rheumatol 29:1207–1210PubMed
3.
Zurück zum Zitat Urowitz MB, Gladman DD, Tom BD, Ibanez D, Farewell VT (2008) Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus. J Rheumatol 35:2152–2158CrossRefPubMed Urowitz MB, Gladman DD, Tom BD, Ibanez D, Farewell VT (2008) Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus. J Rheumatol 35:2152–2158CrossRefPubMed
4.
Zurück zum Zitat Urowitz MB, Gladman DD (2005) Contributions of observational cohort studies in systemic lupus erythematosus: the university of toronto lupus clinic experience. Rheum Dis Clin N Am 31:211–221CrossRef Urowitz MB, Gladman DD (2005) Contributions of observational cohort studies in systemic lupus erythematosus: the university of toronto lupus clinic experience. Rheum Dis Clin N Am 31:211–221CrossRef
5.
Zurück zum Zitat Touma Z, Gladman DD, Urowitz MB (2013) Clinical measures, metrics and indices. In: Dubois lupus erythematosus and related syndromes, 8th edn. Elsevier Saunders, Publisher, pp 563–581CrossRef Touma Z, Gladman DD, Urowitz MB (2013) Clinical measures, metrics and indices. In: Dubois lupus erythematosus and related syndromes, 8th edn. Elsevier Saunders, Publisher, pp 563–581CrossRef
6.
Zurück zum Zitat Zink A, Fischer-Betz R, Thiele K, Listing J, Huscher D, Gromnica-Ihle E et al (2004) Health care and burden of illness in systemic lupus erythematosus compared to rheumatoid arthritis: results from the National Database of the German Collaborative Arthritis Centres. Lupus 13:529–536CrossRefPubMed Zink A, Fischer-Betz R, Thiele K, Listing J, Huscher D, Gromnica-Ihle E et al (2004) Health care and burden of illness in systemic lupus erythematosus compared to rheumatoid arthritis: results from the National Database of the German Collaborative Arthritis Centres. Lupus 13:529–536CrossRefPubMed
7.
Zurück zum Zitat Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725CrossRefPubMed Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725CrossRefPubMed
8.
Zurück zum Zitat Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277CrossRefPubMed Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277CrossRefPubMed
9.
Zurück zum Zitat Gladman DD, Ibanez D, Urowitz MB (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29:288–291PubMed Gladman DD, Ibanez D, Urowitz MB (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29:288–291PubMed
10.
Zurück zum Zitat Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M et al (1996) The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39:363–369CrossRefPubMed Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M et al (1996) The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39:363–369CrossRefPubMed
11.
Zurück zum Zitat Swaak AJ, Nossent JC, Bronsveld W, Van Rooyen A, Nieuwenhuys EJ, Theuns L et al (1989) Systemic lupus erythematosus. I. Outcome and survival: Dutch experience with 110 patients studied prospectively. Ann Rheum Dis 48:447–454CrossRefPubMedPubMedCentral Swaak AJ, Nossent JC, Bronsveld W, Van Rooyen A, Nieuwenhuys EJ, Theuns L et al (1989) Systemic lupus erythematosus. I. Outcome and survival: Dutch experience with 110 patients studied prospectively. Ann Rheum Dis 48:447–454CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Ruiz-Irastorza G, Danza A, Khamashta M (2012) Glucocorticoid use and abuse in SLE. Rheumatology (Oxford, England) 51(7):1145–1153CrossRef Ruiz-Irastorza G, Danza A, Khamashta M (2012) Glucocorticoid use and abuse in SLE. Rheumatology (Oxford, England) 51(7):1145–1153CrossRef
13.
Zurück zum Zitat Urowitz M, Gladman D, Bruce I (2000) Atherosclerosis and systemic lupus erythematosus. Curr Rheumatol Rep 2(1):19–23CrossRefPubMed Urowitz M, Gladman D, Bruce I (2000) Atherosclerosis and systemic lupus erythematosus. Curr Rheumatol Rep 2(1):19–23CrossRefPubMed
14.
Zurück zum Zitat Bruce IN, Urowitz MB, Gladman DD, Hallett DC (1999) Natural history of hypercholesterolemia in systemic lupus erythematosus. J Rheumatol 26:2137–2143PubMed Bruce IN, Urowitz MB, Gladman DD, Hallett DC (1999) Natural history of hypercholesterolemia in systemic lupus erythematosus. J Rheumatol 26:2137–2143PubMed
15.
Zurück zum Zitat Molina MJ, Mayor AM, Franco AE, Morell CA, Lopez MA, Vila LM (2008) Utilization of health services and prescription patterns among lupus patients followed by primary care physicians and rheumatologists in Puerto Rico. Ethn Dis 18(Suppl 2):S2–205-10PubMedPubMedCentral Molina MJ, Mayor AM, Franco AE, Morell CA, Lopez MA, Vila LM (2008) Utilization of health services and prescription patterns among lupus patients followed by primary care physicians and rheumatologists in Puerto Rico. Ethn Dis 18(Suppl 2):S2–205-10PubMedPubMedCentral
16.
Zurück zum Zitat Curtis JR, Westfall AO, Allison JJ, Becker A, Casebeer L, Freeman A et al (2005) Longitudinal patterns in the prevention of osteoporosis in glucocorticoid-treated patients. Arthritis Rheum 52:2485–2494CrossRefPubMed Curtis JR, Westfall AO, Allison JJ, Becker A, Casebeer L, Freeman A et al (2005) Longitudinal patterns in the prevention of osteoporosis in glucocorticoid-treated patients. Arthritis Rheum 52:2485–2494CrossRefPubMed
17.
Zurück zum Zitat Yood RA, Harrold LR, Fish L, Cernieux J, Emani S, Conboy E et al (2001) Prevention of glucocorticoid-induced osteoporosis: experience in a managed care setting. Arch Intern Med 161:1322–1327CrossRefPubMed Yood RA, Harrold LR, Fish L, Cernieux J, Emani S, Conboy E et al (2001) Prevention of glucocorticoid-induced osteoporosis: experience in a managed care setting. Arch Intern Med 161:1322–1327CrossRefPubMed
18.
Zurück zum Zitat Schmajuk G, Yazdany J, Trupin L, Yelin E (2010) Hydroxychloroquine treatment in a community-based cohort of patients with systemic lupus erythematosus. Arthritis Care Res (Hoboken) 62:386–392CrossRef Schmajuk G, Yazdany J, Trupin L, Yelin E (2010) Hydroxychloroquine treatment in a community-based cohort of patients with systemic lupus erythematosus. Arthritis Care Res (Hoboken) 62:386–392CrossRef
19.
Zurück zum Zitat Tam LS, Gladman DD, Hallett DC, Rahman P, Urowitz MB (2000) Effect of antimalarial agents on the fasting lipid profile in systemic lupus erythematosus. J Rheumatol 27:2142–2145PubMed Tam LS, Gladman DD, Hallett DC, Rahman P, Urowitz MB (2000) Effect of antimalarial agents on the fasting lipid profile in systemic lupus erythematosus. J Rheumatol 27:2142–2145PubMed
20.
Zurück zum Zitat Fessler BJ, Alarcon GS, McGwin G Jr, Roseman J, Bastian HM, Friedman AW et al (2005) Systemic lupus erythematosus in three ethnic groups: XVI. Association of hydroxychloroquine use with reduced risk of damage accrual. Arthritis Rheum 52:1473–1480CrossRefPubMed Fessler BJ, Alarcon GS, McGwin G Jr, Roseman J, Bastian HM, Friedman AW et al (2005) Systemic lupus erythematosus in three ethnic groups: XVI. Association of hydroxychloroquine use with reduced risk of damage accrual. Arthritis Rheum 52:1473–1480CrossRefPubMed
21.
Zurück zum Zitat Molad Y, Gorshtein A, Wysenbeek AJ, Guedj D, Majadla R, Weinberger A et al (2002) Protective effect of hydroxychloroquine in systemic lupus erythematosus. Prospective long-term study of an Israeli cohort. Lupus 11:356–361CrossRefPubMed Molad Y, Gorshtein A, Wysenbeek AJ, Guedj D, Majadla R, Weinberger A et al (2002) Protective effect of hydroxychloroquine in systemic lupus erythematosus. Prospective long-term study of an Israeli cohort. Lupus 11:356–361CrossRefPubMed
22.
Zurück zum Zitat Ho KT, Ahn CW, Alarcon GS, Baethge BA, Tan FK, Roseman J et al (2005) Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXVIII. Factors predictive of thrombotic events. Rheumatology (Oxford, England) 44:1303–1307CrossRef Ho KT, Ahn CW, Alarcon GS, Baethge BA, Tan FK, Roseman J et al (2005) Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXVIII. Factors predictive of thrombotic events. Rheumatology (Oxford, England) 44:1303–1307CrossRef
23.
Zurück zum Zitat Rahman P, Gladman DD, Urowitz MB, Yuen K, Hallett D, Bruce IN (1999) The cholesterol lowering effect of antimalarial drugs is enhanced in patients with lupus taking corticosteroid drugs. J Rheumatol 26:325–330PubMed Rahman P, Gladman DD, Urowitz MB, Yuen K, Hallett D, Bruce IN (1999) The cholesterol lowering effect of antimalarial drugs is enhanced in patients with lupus taking corticosteroid drugs. J Rheumatol 26:325–330PubMed
24.
Zurück zum Zitat Lakshminarayanan S, Walsh S, Mohanraj M, Rothfield N (2001) Factors associated with low bone mineral density in female patients with systemic lupus erythematosus. J Rheumatol 28:102–108PubMed Lakshminarayanan S, Walsh S, Mohanraj M, Rothfield N (2001) Factors associated with low bone mineral density in female patients with systemic lupus erythematosus. J Rheumatol 28:102–108PubMed
Metadaten
Titel
Comparison of systemic lupus erythematosus (SLE) patients managed early after diagnosis in specialty versus community care clinics
verfasst von
Roaa Aljohani
Dafna D. Gladman
Jiandong Su
Murray B. Urowitz
Publikationsdatum
06.06.2017
Verlag
Springer London
Erschienen in
Clinical Rheumatology / Ausgabe 8/2017
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-017-3713-7

Weitere Artikel der Ausgabe 8/2017

Clinical Rheumatology 8/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.